Skip to main content
Top
Published in:

Open Access 01-12-2024 | Research

Association of tea consumption with life expectancy in US adults

Authors: Wei Tian, Yafeng Zhang, Shanjie Wang, Jie Yan, Yao Wang, Jiahui Pan, Yun Yan, Guangcan Yan, Wenran Zhao

Published in: Nutrition Journal | Issue 1/2024

Login to get access

Abstract

Objective

The association of tea consumption with life expectancy in US adults remains unclear. This study aimed to evaluate the correlation between tea consumption and life expectancy among US adults.

Methods

Tea consumption records and available mortality data from National Health and Nutrition Examination Survey 2001 to 2018 for adults ≥ 20 years of age were used (n = 43,276). Participants were grouped based on their daily tea consumption as follows: non-drinkers, < 1 cup/day, 1 to < 3 cups/day, 3 to < 5 cups/day, and ≥ 5 cups/day. Life table method was used to evaluate the association between daily tea consumption and life expectancy.

Results

During a median follow-up of 8.7 years, we documented 6275 deaths out of the 43,276 participants. The estimated life expectancy at age 50 years was 30.69 years (95% confidence interval, 30.53 to 30.89), 30.77 years (29.45 to 32.19), 31.07 years (30.35 to 31.69), 32.93 years (31.24 to 34.5), and 29.68 years (27.38 to 31.97) in tea-consuming participants with non-drinker, < 1 cup/day, 1 to < 3 cups/day, 3 to < 5 cups/day, and ≥ 5 cups/day, respectively. Equivalently, participants with 3 to < 5 cups/day consumption had a life gain of average 2.24 years (0.49 to 3.85) compared with those without tea consumption. Similar years of life gained were observed in females and White individuals, but not in males, Black and Hispanic populations. Notably, obvious health benefits weren’t observed in other groups of tea consumption. The addition of sugar to tea is a potential health risk factor.

Conclusions

Consuming 3 to < 5 cups/day of tea may be a healthy recommendation for tea intake, and the addition of sugar to tea should be approached with caution.
Appendix
Available only for authorised users
Literature
1.
go back to reference Martin AB, Hartman M, Benson J, Catlin A, Team TN, H.E.A. National Health Care Spending In 2021. Decline in federal spending Outweighs Greater Use of Health Care. Health Aff (Millwood). 2023;42:6–17.CrossRefPubMed Martin AB, Hartman M, Benson J, Catlin A, Team TN, H.E.A. National Health Care Spending In 2021. Decline in federal spending Outweighs Greater Use of Health Care. Health Aff (Millwood). 2023;42:6–17.CrossRefPubMed
3.
go back to reference Shanahan L, Copeland WE. A Deadly Drop in Rankings: how the United States was left behind in Global Life Expectancy trends. Am J Public Health. 2023;113:961–3.CrossRefPubMedPubMedCentral Shanahan L, Copeland WE. A Deadly Drop in Rankings: how the United States was left behind in Global Life Expectancy trends. Am J Public Health. 2023;113:961–3.CrossRefPubMedPubMedCentral
5.
go back to reference Acosta E, Mehta N, Myrskylä M, Ebeling M. Cardiovascular Mortality Gap between the United States and Other High Life Expectancy Countries in 2000–2016. J Gerontol B Psychol Sci Soc Sci. 2022;77:S148–148157.CrossRefPubMedPubMedCentral Acosta E, Mehta N, Myrskylä M, Ebeling M. Cardiovascular Mortality Gap between the United States and Other High Life Expectancy Countries in 2000–2016. J Gerontol B Psychol Sci Soc Sci. 2022;77:S148–148157.CrossRefPubMedPubMedCentral
6.
go back to reference Hayat K, Iqbal H, Malik U, Bilal U, Mushtaq S. Tea and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2015;55:939–54.CrossRefPubMed Hayat K, Iqbal H, Malik U, Bilal U, Mushtaq S. Tea and its consumption: benefits and risks. Crit Rev Food Sci Nutr. 2015;55:939–54.CrossRefPubMed
7.
go back to reference Chen Y, Zhang Y, Zhang M, Yang H, Wang Y. Consumption of coffee and tea with all-cause and cause-specific mortality: a prospective cohort study. BMC Med. 2022;20:449.CrossRefPubMedPubMedCentral Chen Y, Zhang Y, Zhang M, Yang H, Wang Y. Consumption of coffee and tea with all-cause and cause-specific mortality: a prospective cohort study. BMC Med. 2022;20:449.CrossRefPubMedPubMedCentral
8.
go back to reference Chieng D, Kistler PM. Coffee and tea on cardiovascular disease (CVD) prevention. Trends Cardiovasc Med. 2022;32:399–405.CrossRefPubMed Chieng D, Kistler PM. Coffee and tea on cardiovascular disease (CVD) prevention. Trends Cardiovasc Med. 2022;32:399–405.CrossRefPubMed
9.
go back to reference Shin S, Lee JE, Loftfield E, Shu XO, Abe SK, Rahman MS, Saito E, Islam MR, Tsugane S, Sawada N, et al. Coffee and tea consumption and mortality from all causes, cardiovascular disease and cancer: a pooled analysis of prospective studies from the Asia Cohort Consortium. Int J Epidemiol. 2022;51:626–40.CrossRefPubMed Shin S, Lee JE, Loftfield E, Shu XO, Abe SK, Rahman MS, Saito E, Islam MR, Tsugane S, Sawada N, et al. Coffee and tea consumption and mortality from all causes, cardiovascular disease and cancer: a pooled analysis of prospective studies from the Asia Cohort Consortium. Int J Epidemiol. 2022;51:626–40.CrossRefPubMed
11.
go back to reference Wang X, Liu F, Li J, Yang X, Chen J, Cao J, Wu X, Lu X, Huang J, Li Y, et al. Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: the China-PAR project. Eur J Prev Cardiol. 2020;27:1956–63.CrossRefPubMed Wang X, Liu F, Li J, Yang X, Chen J, Cao J, Wu X, Lu X, Huang J, Li Y, et al. Tea consumption and the risk of atherosclerotic cardiovascular disease and all-cause mortality: the China-PAR project. Eur J Prev Cardiol. 2020;27:1956–63.CrossRefPubMed
12.
go back to reference Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson C. Update on NHANES Dietary Data: Focus on Collection, Release, Analytical considerations, and uses to inform Public Policy. Adv Nutr. 2016;7:121–34.CrossRefPubMedPubMedCentral Ahluwalia N, Dwyer J, Terry A, Moshfegh A, Johnson C. Update on NHANES Dietary Data: Focus on Collection, Release, Analytical considerations, and uses to inform Public Policy. Adv Nutr. 2016;7:121–34.CrossRefPubMedPubMedCentral
13.
go back to reference Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital Health Stat 1 2013:1–37. Zipf G, Chiappa M, Porter KS, Ostchega Y, Lewis BG, Dostal J. National health and nutrition examination survey: plan and operations, 1999–2010. Vital Health Stat 1 2013:1–37.
15.
go back to reference Arias E, Xu J. United States Life Tables, 2019. Natl Vital Stat Rep. 2022;70:1–59.PubMed Arias E, Xu J. United States Life Tables, 2019. Natl Vital Stat Rep. 2022;70:1–59.PubMed
16.
go back to reference Yan G, Zhang Q, Yan Y, Zhang Y, Li Y, Liu M, et al. Trends in the prevalence and treatment of comorbid depression among US adults with and without cancer, 2005–2020. J Affect Disord. 2023;340:743–50.CrossRefPubMed Yan G, Zhang Q, Yan Y, Zhang Y, Li Y, Liu M, et al. Trends in the prevalence and treatment of comorbid depression among US adults with and without cancer, 2005–2020. J Affect Disord. 2023;340:743–50.CrossRefPubMed
18.
go back to reference van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1–67.CrossRef van Buuren S, Groothuis-Oudshoorn K. Mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45:1–67.CrossRef
19.
go back to reference Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515–26.CrossRef Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika. 1994;81:515–26.CrossRef
20.
go back to reference Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, O’Keeffe LM, Gao P, Wood AM, Burgess S, et al. Association of Cardiometabolic Multimorbidity with Mortality. JAMA. 2015;314:52–60.CrossRefPubMed Di Angelantonio E, Kaptoge S, Wormser D, Willeit P, Butterworth AS, Bansal N, O’Keeffe LM, Gao P, Wood AM, Burgess S, et al. Association of Cardiometabolic Multimorbidity with Mortality. JAMA. 2015;314:52–60.CrossRefPubMed
21.
go back to reference Li Y, Pan A, Wang DD, Liu X, Dhana K, Franco OH, Kaptoge S, Di Angelantonio E, Stampfer M, Willett WC, et al. Impact of healthy lifestyle factors on life expectancies in the US Population. Circulation. 2018;138:345–55.CrossRefPubMedPubMedCentral Li Y, Pan A, Wang DD, Liu X, Dhana K, Franco OH, Kaptoge S, Di Angelantonio E, Stampfer M, Willett WC, et al. Impact of healthy lifestyle factors on life expectancies in the US Population. Circulation. 2018;138:345–55.CrossRefPubMedPubMedCentral
22.
go back to reference Ma H, Wang X, Xue Q, Li X, Liang Z, Heianza Y, Franco OH, Qi L. Cardiovascular Health and Life Expectancy among adults in the United States. Circulation. 2023;147:1137–46.CrossRefPubMedPubMedCentral Ma H, Wang X, Xue Q, Li X, Liang Z, Heianza Y, Franco OH, Qi L. Cardiovascular Health and Life Expectancy among adults in the United States. Circulation. 2023;147:1137–46.CrossRefPubMedPubMedCentral
23.
go back to reference Chiang CL, World Health Organization. Life table and mortality analysis. Publisher: Geneva: World Health Organization; 1979. Chiang CL, World Health Organization. Life table and mortality analysis. Publisher: Geneva: World Health Organization; 1979.
25.
26.
go back to reference Auger N, Feuillet P, Martel S, Lo E, Barry AD, Harper S. Mortality inequality in populations with equal life expectancy: Arriaga’s decomposition method in SAS, Stata, and Excel. Ann Epidemiol 2014;24:575 – 80, 580.e1. Auger N, Feuillet P, Martel S, Lo E, Barry AD, Harper S. Mortality inequality in populations with equal life expectancy: Arriaga’s decomposition method in SAS, Stata, and Excel. Ann Epidemiol 2014;24:575 – 80, 580.e1.
27.
go back to reference Zhang YB, Chen C, Pan XF, Guo J, Li Y, Franco OH, Liu G, Pan A. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies. BMJ. 2021;373:n604.CrossRefPubMedPubMedCentral Zhang YB, Chen C, Pan XF, Guo J, Li Y, Franco OH, Liu G, Pan A. Associations of healthy lifestyle and socioeconomic status with mortality and incident cardiovascular disease: two prospective cohort studies. BMJ. 2021;373:n604.CrossRefPubMedPubMedCentral
28.
go back to reference Ten great public health achievements–United States. 2001–2010. MMWR Morb Mortal Wkly Rep. 2011;60:619–23. Ten great public health achievements–United States. 2001–2010. MMWR Morb Mortal Wkly Rep. 2011;60:619–23.
29.
go back to reference Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: final data for 2014. Natl Vital Stat Rep. 2016;65:1–122.PubMed Kochanek KD, Murphy SL, Xu J, Tejada-Vera B. Deaths: final data for 2014. Natl Vital Stat Rep. 2016;65:1–122.PubMed
30.
go back to reference Ho JY. Causes of America’s Lagging Life Expectancy: An International Comparative Perspective. J Gerontol B Psychol Sci Soc Sci. 2022;77:S117–117126.CrossRefPubMedPubMedCentral Ho JY. Causes of America’s Lagging Life Expectancy: An International Comparative Perspective. J Gerontol B Psychol Sci Soc Sci. 2022;77:S117–117126.CrossRefPubMedPubMedCentral
31.
go back to reference Yang CS, Zhang J, Zhang L, Huang J, Wang Y. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol Nutr Food Res. 2016;60:160–74.CrossRefPubMed Yang CS, Zhang J, Zhang L, Huang J, Wang Y. Mechanisms of body weight reduction and metabolic syndrome alleviation by tea. Mol Nutr Food Res. 2016;60:160–74.CrossRefPubMed
32.
go back to reference Chung M, Zhao N, Wang D, Shams-White M, Karlsen M, Cassidy A, Ferruzzi M, Jacques PF, Johnson EJ, Wallace TC. Dose-response relation between Tea Consumption and Risk of Cardiovascular Disease and all-cause mortality: a systematic review and Meta-analysis of Population-Based studies. Adv Nutr. 2020;11:790–814.CrossRefPubMedPubMedCentral Chung M, Zhao N, Wang D, Shams-White M, Karlsen M, Cassidy A, Ferruzzi M, Jacques PF, Johnson EJ, Wallace TC. Dose-response relation between Tea Consumption and Risk of Cardiovascular Disease and all-cause mortality: a systematic review and Meta-analysis of Population-Based studies. Adv Nutr. 2020;11:790–814.CrossRefPubMedPubMedCentral
33.
go back to reference Ma C, Zheng X, Yang Y, Bu P. The effect of black tea supplementation on blood pressure: a systematic review and dose-response meta-analysis of randomized controlled trials. Food Funct. 2021;12:41–56.CrossRefPubMed Ma C, Zheng X, Yang Y, Bu P. The effect of black tea supplementation on blood pressure: a systematic review and dose-response meta-analysis of randomized controlled trials. Food Funct. 2021;12:41–56.CrossRefPubMed
34.
go back to reference Ma L, Hu Y, Alperet DJ, Liu G, Malik V, Manson JE, Rimm EB, Hu FB, Sun Q. Beverage consumption and mortality among adults with type 2 diabetes: prospective cohort study. BMJ. 2023;381:e073406.CrossRefPubMedPubMedCentral Ma L, Hu Y, Alperet DJ, Liu G, Malik V, Manson JE, Rimm EB, Hu FB, Sun Q. Beverage consumption and mortality among adults with type 2 diabetes: prospective cohort study. BMJ. 2023;381:e073406.CrossRefPubMedPubMedCentral
35.
go back to reference Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol. 2015;30:103–13.CrossRefPubMed Zhang C, Qin YY, Wei X, Yu FF, Zhou YH, He J. Tea consumption and risk of cardiovascular outcomes and total mortality: a systematic review and meta-analysis of prospective observational studies. Eur J Epidemiol. 2015;30:103–13.CrossRefPubMed
36.
go back to reference Inoue-Choi M, Ramirez Y, Cornelis MC, Berrington de González A, Freedman ND, Loftfield E. Tea consumption and all-cause and cause-specific mortality in the UK Biobank: a prospective cohort study. Ann Intern Med. 2022;175:1201–11.CrossRefPubMedPubMedCentral Inoue-Choi M, Ramirez Y, Cornelis MC, Berrington de González A, Freedman ND, Loftfield E. Tea consumption and all-cause and cause-specific mortality in the UK Biobank: a prospective cohort study. Ann Intern Med. 2022;175:1201–11.CrossRefPubMedPubMedCentral
37.
go back to reference Sharpe E, Hua F, Schuckers S, Andreescu S, Bradley R. Effects of brewing conditions on the antioxidant capacity of twenty-four commercial green tea varieties. Food Chem. 2016;192:380–7.CrossRefPubMed Sharpe E, Hua F, Schuckers S, Andreescu S, Bradley R. Effects of brewing conditions on the antioxidant capacity of twenty-four commercial green tea varieties. Food Chem. 2016;192:380–7.CrossRefPubMed
39.
go back to reference Huang Y, Chen Z, Chen B, Li J, Yuan X, Li J, Wang W, Dai T, Chen H, Wang Y, et al. Dietary sugar consumption and health: umbrella review. BMJ. 2023;381:e071609.CrossRefPubMedPubMedCentral Huang Y, Chen Z, Chen B, Li J, Yuan X, Li J, Wang W, Dai T, Chen H, Wang Y, et al. Dietary sugar consumption and health: umbrella review. BMJ. 2023;381:e071609.CrossRefPubMedPubMedCentral
40.
go back to reference Wang ZM, Zhou B, Wang YS, Gong QY, Wang QM, Yan JJ, Gao W, Wang LS. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr. 2011;93:506–15.CrossRefPubMed Wang ZM, Zhou B, Wang YS, Gong QY, Wang QM, Yan JJ, Gao W, Wang LS. Black and green tea consumption and the risk of coronary artery disease: a meta-analysis. Am J Clin Nutr. 2011;93:506–15.CrossRefPubMed
41.
go back to reference Naumovski N, Foscolou A, D’Cunha NM, Tyrovolas S, Chrysohoou C, Sidossis LS, Rallidis L, Matalas AL, Polychronopoulos E, Pitsavos C, et al. The Association between Green and Black Tea Consumption on successful aging: a combined analysis of the ATTICA and MEDiterranean ISlands (MEDIS) Epidemiological studies. Molecules. 2019;24:1862.CrossRefPubMedPubMedCentral Naumovski N, Foscolou A, D’Cunha NM, Tyrovolas S, Chrysohoou C, Sidossis LS, Rallidis L, Matalas AL, Polychronopoulos E, Pitsavos C, et al. The Association between Green and Black Tea Consumption on successful aging: a combined analysis of the ATTICA and MEDiterranean ISlands (MEDIS) Epidemiological studies. Molecules. 2019;24:1862.CrossRefPubMedPubMedCentral
Metadata
Title
Association of tea consumption with life expectancy in US adults
Authors
Wei Tian
Yafeng Zhang
Shanjie Wang
Jie Yan
Yao Wang
Jiahui Pan
Yun Yan
Guangcan Yan
Wenran Zhao
Publication date
01-12-2024
Publisher
BioMed Central
Published in
Nutrition Journal / Issue 1/2024
Electronic ISSN: 1475-2891
DOI
https://doi.org/10.1186/s12937-024-01054-9

Keynote series | Spotlight on menopause

Menopause can have a significant impact on the body, with effects ranging beyond the endocrine and reproductive systems. Learn about the broader systemic effects of menopause, so you can help patients in your clinics through the transition.

Launching: Thursday 12th December 2024
 

Prof. Martha Hickey
Dr. Claudia Barth
Dr. Samar El Khoudary
Developed by: Springer Medicine
Register your interest now

Keynote webinar | Spotlight on adolescent vaping

  • Live
  • Webinar | 29-01-2025 | 18:00 (CET)

Growing numbers of young people are using e-cigarettes, despite warnings of respiratory effects and addiction. How can doctors tackle the epidemic, and what health effects should you prepare to manage in your clinics?

Watch it live: Wednesday 29th January, 18:00-19:30 CET
 

Prof. Ann McNeill
Dr. Debbie Robson
Benji Horwell
Developed by: Springer Medicine
Join the webinar

Keynote webinar | Spotlight on modern management of frailty

Frailty has a significant impact on health and wellbeing, especially in older adults. Our experts explain the factors that contribute to the development of frailty and how you can manage the condition and reduce the risk of disability, dependency, and mortality in your patients.

Prof. Alfonso Cruz-Jentoft
Prof. Barbara C. van Munster
Prof. Mirko Petrovic
Developed by: Springer Medicine
Watch now

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine
Read more